97 related articles for article (PubMed ID: 31787232)
21. AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C.
Vucicevic L; Misirkic M; Janjetovic K; Harhaji-Trajkovic L; Prica M; Stevanovic D; Isenovic E; Sudar E; Sumarac-Dumanovic M; Micic D; Trajkovic V
Biochem Pharmacol; 2009 Jun; 77(11):1684-93. PubMed ID: 19428322
[TBL] [Abstract][Full Text] [Related]
22. AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells.
Yang WL; Perillo W; Liou D; Marambaud P; Wang P
J Surg Oncol; 2012 Nov; 106(6):680-8. PubMed ID: 22674626
[TBL] [Abstract][Full Text] [Related]
23. Involvement of AMP-activated protein kinase and p38 mitogen-activated protein kinase in 8-Cl-cAMP-induced growth inhibition.
Han JH; Ahn YH; Choi KY; Hong SH
J Cell Physiol; 2009 Jan; 218(1):104-12. PubMed ID: 18756496
[TBL] [Abstract][Full Text] [Related]
24. Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway.
Park JB; Lee MS; Cha EY; Lee JS; Sul JY; Song IS; Kim JY
Biol Pharm Bull; 2012; 35(9):1614-20. PubMed ID: 22975518
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia promotes AMP-activated protein kinase (AMPK) and induces apoptosis in mouse osteoblasts.
Hao Z; Ma Y; Wang J; Fan D; Han C; Wang Y; Ji Y; Wen S
Int J Clin Exp Pathol; 2015; 8(5):4892-902. PubMed ID: 26191182
[TBL] [Abstract][Full Text] [Related]
26. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1.
Jang JH; Lee TJ; Yang ES; Min do S; Kim YH; Kim SH; Choi YH; Park JW; Choi KS; Kwon TK
Exp Cell Res; 2010 Aug; 316(13):2194-203. PubMed ID: 20451517
[TBL] [Abstract][Full Text] [Related]
27. AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.
Dite TA; Langendorf CG; Hoque A; Galic S; Rebello RJ; Ovens AJ; Lindqvist LM; Ngoei KRW; Ling NXY; Furic L; Kemp BE; Scott JW; Oakhill JS
J Biol Chem; 2018 Jun; 293(23):8874-8885. PubMed ID: 29695504
[TBL] [Abstract][Full Text] [Related]
28. AMP-activated kinase is a regulator of fibroblast growth factor 23 production.
Glosse P; Feger M; Mutig K; Chen H; Hirche F; Hasan AA; Gaballa MMS; Hocher B; Lang F; Föller M
Kidney Int; 2018 Sep; 94(3):491-501. PubMed ID: 29861059
[TBL] [Abstract][Full Text] [Related]
29. AMP-activated protein kinase is required for induction of apoptosis and epithelial-to-mesenchymal transition.
Wang X; Pan X; Song J
Cell Signal; 2010 Nov; 22(11):1790-7. PubMed ID: 20650315
[TBL] [Abstract][Full Text] [Related]
30. Dorsomorphin inhibits AMPK, upregulates Wnt and Foxo genes and promotes the activation of dormant follicles.
Madsen JF; Ernst EH; Amoushahi M; Dueholm M; Ernst E; Lykke-Hartmann K
Commun Biol; 2024 Jun; 7(1):747. PubMed ID: 38902324
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
32. Adenosine monophosphate activated protein kinase regulates ABCG1-mediated oxysterol efflux from endothelial cells and protects against hypercholesterolemia-induced endothelial dysfunction.
Li D; Zhang Y; Ma J; Ling W; Xia M
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1354-62. PubMed ID: 20395595
[TBL] [Abstract][Full Text] [Related]
33. AMPK-dependent and independent effects of AICAR and compound C on T-cell responses.
Rao E; Zhang Y; Li Q; Hao J; Egilmez NK; Suttles J; Li B
Oncotarget; 2016 Jun; 7(23):33783-95. PubMed ID: 27177226
[TBL] [Abstract][Full Text] [Related]
34. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent.
Liu X; Chhipa RR; Nakano I; Dasgupta B
Mol Cancer Ther; 2014 Mar; 13(3):596-605. PubMed ID: 24419061
[TBL] [Abstract][Full Text] [Related]
35. AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin.
Lee YK; Park SY; Kim YM; Lee WS; Park OJ
Exp Mol Med; 2009 Mar; 41(3):201-7. PubMed ID: 19293639
[TBL] [Abstract][Full Text] [Related]
36. AMP-activated protein kinase phosphorylates transcription factors of the CREB family.
Thomson DM; Herway ST; Fillmore N; Kim H; Brown JD; Barrow JR; Winder WW
J Appl Physiol (1985); 2008 Feb; 104(2):429-38. PubMed ID: 18063805
[TBL] [Abstract][Full Text] [Related]
37. Identifying New AMP-Activated Protein Kinase Inhibitors That Protect against Ischemic Brain Injury.
Eom JW; Kim TY; Seo BR; Park H; Koh JY; Kim YH
ACS Chem Neurosci; 2019 May; 10(5):2345-2354. PubMed ID: 30763060
[TBL] [Abstract][Full Text] [Related]
38. Alisertib induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells.
Fu Y; Zhang Y; Gao M; Quan L; Gui R; Liu J
Mol Med Rep; 2016 Jul; 14(1):394-8. PubMed ID: 27177156
[TBL] [Abstract][Full Text] [Related]
39. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
Sanli T; Rashid A; Liu C; Harding S; Bristow RG; Cutz JC; Singh G; Wright J; Tsakiridis T
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):221-9. PubMed ID: 20615625
[TBL] [Abstract][Full Text] [Related]
40. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
